July 2026: Government declines to widen the Thirlwall terms of reference (16 July) · new 100-page insulin report to the CCRC challenging the trial evidence (9 July) · Thirlwall report still expected no earlier than September · inquests relisted to 2027 · Shoo Lee Panel: no medical evidence of deliberate harm.
Dr Jane Hawdon, consultant neonatologist and external reviewer, gave Thirlwall Inquiry evidence on the reviews commissioned around the cluster and the constraints under which those reviews operated.
Editorial summary — not a verbatim transcript.
This page is a summary written for this site. It is not a mirror of the primary document, and nothing on it should be quoted as the words of any person. An earlier version of this page carried quotations that could not be verified against the primary record; those have been removed. For the underlying record, consult the primary source at thirlwall.public-inquiry.uk. See our corrections policy.
Status: Editorial summary written for this site — not a mirrored document
Original source: thirlwall.public-inquiry.uk
Dr Jane Hawdon is a consultant neonatologist and experienced external reviewer. She gave Thirlwall Inquiry evidence on the reviews commissioned around the cluster and the structural constraints under which those reviews operated — particularly the terms of reference set by the commissioning Trust.